This is out Library. Please click on the article title to view the details.
submitted by: admin on 06/18/2016
In a field plagued by frequent controversy, the American Cancer Society (ACS) claims to have taken a major step forward to provide transparency in how justified it is in recommending cancer screening tests. It blames oncologists with a conflict of interest...what would you expect from an organization that depends on income from big pharma and the mammography...
submitted by: admin on 11/24/2019
Flagging medical errors and emphasizing lack of punishment by maintaining anonymity leads to more reporting of errors. There are 100,000 deaths from medical errors annually according to the Institute of Medicine (IOM). A study published in the November 21 issue of Pediatrics showed that reports increased from 13 over 2.5 years to 216. However, none of the reports...
submitted by: admin on 09/19/2013
The European "FDA" or European Medicines Agency (EMA) is in the process of opening its drug industry's research to independent researchers so they can test company claims and expose product deficiencies. This will bring long sought after transparency to Big Pharma's research and claims made on their behalf. Both the FDA and...
submitted by: admin on 09/19/2013
During the early post-health care reform era, HHS claimed to be keeping a close watch on insurance companies to make sure they comply with their new regulations. There is great reason to doubt that this will be so easy in view of how insurance companies had such a powerful influence in protecting their interests.
submitted by: admin on 10/06/2024
It is important to express yourself if you're going to be authentic. All too often we only present the tip of the iceberg. This means exposing more of who we are. Honesty and transparency make you vulnerable; be that way anyway! We are only as sick as our secrets.
submitted by: admin on 09/23/2013
What real health care reform is being discussed? The corruption between Congress and the health care industry is explored and the potential outcome of the proposed bill is discussed. The lack of transparency is discussed.
submitted by: admin on 10/14/2013
A lack of openness about designs and results of clinical trials, coupled with inadequate oversight of off-label use of drugs and adaverse events, puts consumers of health products at risk. There is also the aspect that government sponsored clinical trials are paid for by the public, yet they must purchase the information when results are published in medical...
submitted by: admin on 10/17/2013
Not Just a Pretty Face: The Ugly Side of the Beauty Industry is an excellent book that talks about the film, "The Story of Cosmetics" including the toxicity and lack of regulation of the cosmetics industry. Makeup, hair dyes, lipstick, and even baby shampoos are linked to cancer, birth defects, fertility problems, skin problems and much more....
submitted by: admin on 10/06/2024
submitted by: admin on 01/01/2021
We all hoped that the year 2020 would be filled with transparency and clear vision. However, it has been filled with anything but transparency. We've experienced a pandemic of corruption, fraud and lies that has made us frustrated, angry, and feeling hopeless. Dr. Len and Francesco review what happened in 2020 with Covid 19 testing, methods of reporting mortality,...